Skip to content
Menu

Are NAD+ Injections FDA-Approved? What Compounding Means

Compounded NAD+ injections are not FDA-approved. Understand pharmacy oversight, ingredient quality and the questions to ask before paying.

By Marcus HaleLongevity Research Editor
Updated

4 min read · 2 sources

On this page

Compounded NAD+ injections are not FDA-approved. FDA does not review a compounded drug for safety, effectiveness and quality before it is marketed. A clinician's prescription, a licensed pharmacy and an FDA-registered facility each answer a different question from product approval 1.

That distinction matters when a program presents a shot as a routine wellness upgrade. You should know both what oversight exists and what clinical evidence is missing before agreeing to a recurring prescription.

Affiliate partner

Peter MD

Physician-prescribed injectable NAD+, sold as a course rather than a monthly plan

See Peter MD

Compounded does not mean FDA-approved

Compounding involves preparing or altering a medicine for a patient's needs. FDA describes an important role for it when an approved medicine cannot meet a patient's medical needs. The resulting drug does not go through the same premarket review as an approved product 1.

Calling a product “pharmaceutical grade” or identifying a facility as “FDA registered” does not change that status. Ask for the dispensing pharmacy's name and verify its license for your state. Ask the clinician to explain the reason for treatment, the intended benefit and the alternatives. None of those checks guarantees a result, but they make the transaction more understandable.

Three separate checks

  • A prescription is an individual clinical decision.
  • A pharmacy license concerns the dispensing business.
  • FDA approval concerns review of the drug product.

What does FDA say about NAD+ ingredient quality?

FDA has specifically identified food-grade NAD+ being used to make IV products and described reports consistent with excessive endotoxin exposure. The concern is the suitability and processing of the ingredient for a sterile drug 2. This is one reason a supplement powder and a pharmacy-prepared injectable cannot be treated as interchangeable.

Ask who prepared the medicine and who handles a suspected quality problem. A sales page saying “tested” is less informative than a pharmacy explaining the applicable sterility and endotoxin controls. The IV safety guide covers the treatment-setting questions too.

Is unapproved the same as illegal?

No. “Not FDA-approved” describes approval status; whether a particular prescription is legally compounded depends on the circumstances and applicable federal and state requirements. It is also different from saying a product is prohibited everywhere. FDA's explanation of compounding is a better starting point than a seller's approval badge 1.

Avoid relying on a single nomination-list category or registration number as proof that a finished NAD+ injection is approved. Regulatory categories and enforcement policies can change, and product approval is a separate process. This article does not establish the legal status of every pharmacy or formulation.

What should the prescriber explain?

Before paying, get clear answers to these questions:

  • What condition or symptom are we addressing, and what outcome would justify continuing?
  • Why use an injection rather than another option?
  • Which pharmacy will dispense the prescription, and is it licensed for my location?
  • What written instructions, storage limits and beyond-use date apply to this specific medicine?
  • Who can I contact promptly if I have a reaction or a label does not match the instructions?

If home administration is proposed, where to inject NAD+ explains why the prescriber's route and training must come first. It does not substitute for a demonstration.

How should this affect your purchase decision?

Do not confuse access with proven benefit. A prescription may make a product available without establishing that it improves energy or slows aging. Our NAD+ basics guide explains the biomarker-versus-benefit distinction, and injection evidence examines the research behind the route.

Use the provider comparison to compare price and plan terms after resolving the medical questions. A lower monthly cost, an attractive vial or a subscription discount does not answer whether treatment is appropriate for you.

Approval, registration, accreditation and testing are separate

The words on a clinic's trust badges are worth reading closely. Product approval concerns a specific medicine and its evaluated uses. A facility registration identifies a business in an oversight system. A professional license concerns the person or business permitted to practice. A test report concerns the samples and measurements actually tested. None should be substituted for the others.

When presented with a certificate, ask what it covers and which product or batch it concerns. A general facility certificate does not establish the amount of NAD+ in the vial you receive. Likewise, an ingredient purity result does not by itself answer every question about a finished sterile preparation. These are useful distinctions when evaluating a claim, rather than a request for patients to run their own laboratory audit.

What would meaningful benefit evidence look like?

For an energy claim, look for a study of the same preparation and route with an appropriate comparison group and a meaningful fatigue or functional outcome. A rise in blood NAD+ is not an approval study and does not establish that the injection helped symptoms. For an aging claim, ask what measurable human result is meant rather than accepting “supports cellular health” as an answer.

Trials also need enough participants and follow-up to address the question. A short observation without a reported problem does not establish the safety of repeated treatment for years. Conversely, finding a quality problem in one preparation does not establish that every pharmacy has the same defect. Both overreassurance and overgeneralization can make a purchase decision worse.

A practical script before your first payment

Try asking: “Please tell me what this prescription is intended to improve, what evidence supports this route, which pharmacy will fill it, and how we will decide whether to continue.” A clear answer should distinguish the clinician's judgment from established trial findings.

Then ask for the financial terms separately: the first fill, later fills, any consultation or membership charge, automatic renewal, cancellation method and refund limits if the clinician finds you ineligible. Regulatory status does not answer any of those questions. Having the answers before paying also makes it easier to assess a more expensive program without mistaking price for evidence.

Frequently asked questions

Are NAD+ shots FDA-approved?

Compounded NAD+ shots are not FDA-approved. FDA does not review them for safety, effectiveness and quality before marketing.

Does FDA-registered mean FDA-approved?

No. Facility registration and drug approval are different. Ask about the specific product, pharmacy and prescription.

Are compounded NAD+ injections automatically illegal?

No. Approval status and compliance with compounding law are separate questions that depend on the product and circumstances.

References

  1. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  2. U.S. Food and Drug Administration (2024). FDA reminds compounders to use ingredients suitable for sterile compounding. FDA. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-use-ingredients-suitable-sterile-compounding

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Related reading